BioScrip, Inc. to Present at the Bank of America Merrill Lynch 2010 Global Health Care Conference

BioScrip, Inc. (Nasdaq: BIOS) today announced that the Company will present at the Bank of America Merrill Lynch 2010 Health Care Conference to be held May 11 - 13, 2010 at The Grand Hyatt Hotel in New York City.

Richard H. Friedman, BioScrip’s Chairman and Chief Executive Officer, Richard M. Smith, President and Chief Operating Officer, and Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer, will present Wednesday, May 12, 2010 at 10:40 am Eastern Time.

Investors may access the live audio web cast of BioScrip’s presentation at the following link: https://www.veracast.com/webcasts/bas/healthcare2010/id15602100.cfm. A replay of the presentation will be available approximately one hour after the conclusion of the live event and may also be accessed at the same URL or through BioScrip’s website at www.bioscrip.com under the “Investor Relations” Section and will remain available through Friday, May 28, 2010.

About BioScrip, Inc.

BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payers and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex health care conditions.

Forward Looking Statements-Safe Harbor

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.

BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024